Skip to main content
Chase Science Co.,Ltd logo

Chase Science Co.,Ltd — Investor Relations & Filings

Ticker · 300941 ISIN · CNE100004CZ0 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 514 across all filing types
Latest filing 2026-05-18 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300941

About Chase Science Co.,Ltd

https://www.echase.cn

Chase Science Co., Ltd. specializes in the research, development, manufacturing, and distribution of medical puncture instruments and laboratory consumables. The company's core product portfolio includes a wide range of medical devices such as safety syringes, insulin syringes, hypodermic needles, and infusion sets designed for clinical use. Additionally, the firm produces specialized veterinary medical instruments and laboratory plasticware. Chase Science emphasizes the integration of safety-engineered technologies into its products to minimize needle-stick injuries and enhance patient care. With a focus on high-precision manufacturing and international quality standards, the company serves a global market, providing essential medical supplies to healthcare facilities and research institutions. Its operations are characterized by a commitment to technological innovation in the field of medical consumables and puncture technology.

Recent filings

Filing Released Lang Actions
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is the official announcement of resolutions passed at the 2025 Annual General Meeting, detailing each agenda item and the voting results by share count and percentages. It is not an AGM presentation (AGM-R) nor just a notice of report publication; it specifically discloses voting outcomes at a shareholder meeting. Therefore, it should be classified as a Declaration of Voting Results (DVA).
2026-05-18 Chinese
北京市康达律师事务所关于福建创识科技股份有限公司2025年年度股东会的法律意见书
AGM Information Classification · 90% confidence The document is a legal opinion letter issued by a law firm regarding the convening, attendance, voting procedures, and results of the company’s 2025 Annual General Meeting. It is not an earnings release, financial report, or management discussion, but rather material prepared specifically for the AGM. As such, it falls under “AGM Information” (materials shared during the Annual General Meeting).
2026-05-18 Chinese
关于持股5%以上股东部分股份质押的公告
Major Shareholding Notification Classification · 82% confidence The document is a shareholder disclosure announcement (in Chinese) regarding the pledge of shares by a shareholder holding over 5% of the company stock. It details the number of shares pledged and the pledge terms. This is not an earnings release, management change, or company buyback. It falls under the category covering notifications of changes or movements in major shareholdings. The best match in our taxonomy is Major Shareholding Notification (MRQ).
2026-05-13 Chinese
关于召开2025年年度股东会的提示性公告
Proxy Solicitation & Information Statement Classification · 85% confidence The document is an official notice of the 2025 annual shareholders meeting, including detailed agenda items, voting proposals, proxy authorization form, registration instructions, and voting procedures. It is sent to shareholders to inform them of the meeting and solicit their votes. This matches the definition of Proxy Solicitation & Information Statement (PSI).
2026-05-12 Chinese
关于举行2025年度业绩说明会的公告
Regulatory Filings Classification · 85% confidence The document is an announcement by the company of its 2025 annual performance explanation meeting (业绩说明会). It references that the 2025 annual report has already been published and invites investors to join a remote session on a specified date. There is no actual financial data, slides, transcript, or presentation content provided—only a meeting invitation. This is a regulatory notice rather than the report itself (10-K/Annual Report), an earnings release, or an investor presentation. It therefore falls into the general regulatory announcement/fallback category: RNS (Regulatory Filings).
2026-05-12 Chinese
关于使用闲置自有资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's plan to use idle funds for cash management, including details about the investment amount, purpose, risk analysis, and board approval. It is a formal disclosure to shareholders and the market about a financing-related activity but does not contain financial statements or detailed financial results. The document length is 1919 characters, which is relatively short and consistent with an announcement rather than a full report. It does not present quarterly or annual financial data, nor is it a transcript or management report. The content fits best under Capital/Financing Update (CAP) as it relates to the company's use of capital for cash management investments.
2026-04-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.